Transplantation of betacellulin-transduced islets improves glucose intolerance in diabetic mice

Experimental and Molecular Medicine

Volumn 46, Issue 5, 2014, Pages

  Song, Mi Young ^a   Bae, Ui Jin ^a   Jang, Kyu Yun ^a   Park, Byung Hyun ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Angiogenesis; Betacellulin; Gene therapy; Islets transplantation

Indexed keywords

BETACELLULIN; GAMMA INTERFERON; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR; SIGNAL PEPTIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; EX VIVO STUDY; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GRAFT SURVIVAL; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS PERFUSION; RAT; ANIMAL; APOPTOSIS; C57BL MOUSE; EXPERIMENTAL DIABETES MELLITUS; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE INTOLERANCE; HUMANS; INSULIN-SECRETING CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED C57BL; RATS;

EID: 84902166378     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2014.24     Document Type: Article

References (28)

1. Ricordi C, Strom TB Clinical islet transplantation: advances and immu-nological challenges. Nat Rev Immunol 2004; 4: 259-268. (Pubitemid 38478661)
2. Shapiro AM, Ricordi C, Hering B.J., Auchincloss H., Lindblad R, Robertson RP et al. International trial of the Edmonton protocol for islet transplantation. New Engl J Med 2006; 355: 1318-1330. (Pubitemid 44465460)
3. Jansson L, Carlsson PO Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002; 45: 749-763.
4. Warnock GL, Meloche RM, Thompson D, Shapiro R.J., Fung M., Ao Z et al. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch Surg 2005; 140: 735-744. (Pubitemid 41175697)
5. Westwell-Roper C., Dai DL, Soukhatcheva G, Potter K.J., van Rooijen N, Ehses JA et al. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011; 187: 2755-2765.
6. Wang X, Meloche M, Verchere C.B., Ou D., Mui A, Warnock GL Improving islet engraftment by gene therapy. J Transplant 2011; 2011: 594851.
7. Shing Y, Christofori G, Hanahan D., Ono Y, Sasada R, Igarashi K et al. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 1993; 259: 1604-1607. (Pubitemid 23114638)
8. Sahin U, Weskamp G, Kelly K., Zhou HM, Higashiyama S, Peschon J et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164: 769-779. (Pubitemid 38282960)
9. Miyagawa J, Hanafusa O, Sasada R., Yamamoto K, Igarashi K, Yamamori K et al. Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. Endocr J 1999; 46: 755-764. (Pubitemid 30074908)
10. Kawaguchi M, Hosotani R, Kogire M., Ida J, Doi R, Koshiba T et al. Autoinduction and growth stimulatory effect of betacellulin in human pancreatic cancer cells. Int J Oncol 2000; 16: 37-41.
11. Saito T, Okada S, Ohshima K., Yamada E, Sato M, Uehara Y et al. Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF. Endocrinology 2004; 145: 4232-4433.
12. Kojima H, Fujimiya M, Matsumura K., Younan P, Imaeda H, Maeda M et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 2003; 9: 596-603. (Pubitemid 36597107)
13. Nagaoka T, Fukuda T, Hashizume T., Nishiyama T, Tada H, Yamada H et al. A betacellulin mutant promotes differentiation of pancreatic acinar AR42J cells into insulin-producing cells with low affinity of binding to ErbB1. J Mol Biol 2008; 380: 83-94.
14. Chen S, Ding J, Yu C., Yang B, Wood DR, Grayburn PA Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1. Gene Ther 2007; 14: 1102-1110. (Pubitemid 47029493)
15. Li L, Yi Z, Seno M., Kojima I. Activin A and betacellulin: effect on regeneration of pancreatic b-cells in neonatal streptozotocin-treated rats. Diabetes 2004; 53: 608-615. (Pubitemid 38270629)
16. Shin S, Li N, Kobayashi N., Yoon JW, Jun HS Remission of diabetes by β-cell regeneration in diabetic mice treated with a recombinant adenovirus expressing betacellulin. Mol Ther 2008; 16: 854-861. (Pubitemid 351587094)
17. Li L, Seno M, Yamada H., Kojima I. Promotion of β-cell regeneration by betacellulin in ninety percent-pancreatectomized rats. Endocrinology 2001; 142: 5379-5385. (Pubitemid 33131971)
18. Paz AH, Salton GD, Ayala-Lugo A, Gomes C., Terraciano P, Scalco R et al. Betacellulin overexpression in mesenchymal stem cells induces insulin secretion in vitro and ameliorates streptozotocin-induced hyperglycemia in rats. Stem Cells Dev 2011; 20: 223-232.
19. Kim HS, Shin HS, Kwak H.J., Cho CH, Lee CO, Koh GY Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase in endothelial cell. FASE B J 2003; 17: 318-320.
20. Bae UJ, Song MY, Jang H.Y., Gim HJ, Ryu JH, Lee SM et al. The efficacy of SPA0355 in protecting b cells in isolated pancreatic islets and in a murine experimental model of type 1 diabetes. Exp Mol Med 2013; 45: e51.
21. Lv N, Kim EK, Song M.Y., Choi HN, Moon WS, Park SJ et al. JANEX-1, a JAK3 inhibitor, protects pancreatic islets from cytokine toxicity through downregulation of NF-κB activation and the JAK/STAT pathway. Exp Cell Res 2009; 315: 2064-2071.
22. Lee HS, Woo SJ, Koh H.W., Ka SO, Zhou L, Jang KY et al. Regulation of apoptosis and inflammatory responses by IGFBP-3 in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis. Arthritis Rheum 2014; 66: 863-873.
23. Moon WS, Park HS, Yu K.H., Park MY, Kim KR, Jang KY et al. Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis. Hum Pathol 2006; 37: 1324-1332. (Pubitemid 44380277)
24. Schneider MR, Antsiferova M, Feldmeyer L., Dahlhoff M, Bugnon P, Hasse S et al. Betacellulin regulates hair follicle development and hair cycle induction and enhances angiogenesis in wounded skin. J Invest Dermatol 2008; 128: 1256-1265. (Pubitemid 351543186)
25. Zhang N, Richter A, Suriawinata J., Harbaran S, Altomonte J, Cong L et al. Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 2004; 53: 963-970. (Pubitemid 38436608)
26. Su D, Zhang N, He J., Qu S, Slusher S, Bottino R et al. Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 2007; 56: 2274-2283. (Pubitemid 47358234)
27. Zhang N, Qu S, Xu J., Bromberg JS, Dong HH Inhibition of angiogenesis is associated with reduced islet engraftment in diabetic recipient mice. Transplant Proc 2005; 37: 4452-4457. (Pubitemid 43016055)
28. Buteau J, Foisy S, Joly E., Prentki M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 2003; 52: 124-132. (Pubitemid 36042116)